AzTrials
AzTrials

Patients in Surgical Intensive CareNCT04261062

Validity Test of Wearable Continuous Blood Pressure Measuring System

An observational study of Patients in Surgical Intensive Care, run by Yonsei University at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. Purpose of Research For the feasibility test of a wearable blood pressure measuring device, biometric data of patients in surgical intensive care is simultaneously obtained and stored from the device and a patient monitor. 2. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Patients in Surgical Intensive Care
How many people
220 participants
Where
1 siteSouth Korea
Study dates
7 May 2020to Jan 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients in surgical intensive care

Who may be able to join

  • Adult patient in surgical intensive care of Severance Hospital
  • Voluntarily agreed to participate the research and not included to the exclusion criteria

Who cannot join

  • Patient with occlusive peripheral arterial disease
  • Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
  • Patient administered high-dose of pressor agent over 15 mcg/min
  • Patient who is not available for measurement of invasive arterial blood pressure
  • Patient who is not available to wear an wearable device on the wrist
  • Pregnant woman, minor

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Yonsei University College of Medicine, Department of Anesthesiology and Pain Medicine

    Seoul

    Jeongmin Kim, 82-2-2227-3569, anesjeongmin@yuhs.ac

    Jeongmin Kim

    Recruiting

Other trials in South Korea

About this study

  1. Purpose of Research For the feasibility test of a wearable blood pressure measuring device, biometric data of patients in surgical intensive care is simultaneously obtained and stored from the device and a patient monitor.
  2. Overview of Research Design This research is simply to obtain and store the data: 1) invasive arterial blood pressure measured with a patient monitor from one wrist, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device from the other wrist.
  3. Medical Device for Clinical Trial Patient monitor (IntelliVue MX700, Philips, NED) and wearable blood pressure measuring device
  4. Target Recruiting Number of Participants Considering the expected patient number in intensive care and 10% dropout rate during the research period, the target recurring number of participants is 220.
  5. Criteria of Participant Inclusion
  6. Adult patient in surgical intensive care of Severance Hospital
  7. Voluntarily agreed to participate the research and not included to the exclusion criteria
  8. Criteria of Participant Exclusion
  9. Patient with occlusive peripheral arterial disease
  10. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
  11. Patient administered high-dose of pressor agent over 15 mcg/min
  12. Patient who is not available for measurement of invasive arterial blood pressure
  13. Patient who is not available to wear an wearable device on the wrist
  14. Pregnant woman, minor
  15. Evaluation Parameter
  16. Systolic and diastolic blood pressure, which extracted in mmHg unit from the continuous blood pressure output of patient monitor.
  17. Blood pressure, which estimated by the signal analysis of multi-wavelength photoplethysmography and pressure signal measured with the wearable device.
  18. Data Analysis and Statistical Methods
  19. From the multi-wavelength photoplethysmography and multi-channel pressure signal measured, continuous blood pressure will be estimated through the hemodynamic model and machine learning model.
  20. For the machine learning model, the data obtained will be divided into the training data and evaluation data, with the ratio of 80% and 20%.
  21. In order to evaluate the accuracy of the estimated blood pressure, the invasive arterial blood pressure will be considered as the reference blood pressure. Between the estimated blood pressure and the reference blood pressure, the correlation and root mean square error (RMSE) will be calculated.
Read the detailed description
  1. Recruit participants.
  2. Explain the research purpose and details, and then have the participant sign the consent form.
  3. Before starting the measurement, gather the participant's information such as age, length, and weight.
  4. Measure noninvasive blood pressure in both arms. Compared to the blood pressure in the arm where inserted a catheter, confirm if difference of systolic or diastolic blood pressure in the other side of arm is not more than 10%.
  5. Wear the wearable device on the opposite wrist from the catheter-inserted.
  6. For 10 minutes, simultaneously obtain the data: 1) invasive arterial blood pressure measured with a patient monitor, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device.
  7. For accuracy of data acquisition, repeat twice the procedure 5-7 by performing it in the morning and in the afternoon with the 5 hours interval.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04261062
Study groupRoleWhat they receive
SubjectPatients in surgical intensive unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Title quality of pulsewave

    Measured: 2 years

Secondary outcomes (1)
  1. User Comfortability

    Abnormal symptoms or discomforts reported in wearing device

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2020
  2. Study start7 May 2020
  3. Primary completionJan 2022 (estimated)
  4. Study completionJan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
220 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04261062
Sponsor's protocol ID
1-2019-0080
Status last verified
Jul 2020
First submitted
6 Feb 2020
Last updated
23 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hughes DJ, Babbs CF, Geddes LA, Bourland JD. Measurements of Young's modulus of elasticity of the canine aorta with ultrasound. Ultrason Imaging. 1979 Oct;1(4):356-67. doi: 10.1177/016173467900100406. No abstract available.

    PubMed 575833
  • Liu J, Yan BP, Dai WX, Ding XR, Zhang YT, Zhao N. Multi-wavelength photoplethysmography method for skin arterial pulse extraction. Biomed Opt Express. 2016 Sep 27;7(10):4313-4326. doi: 10.1364/BOE.7.004313. eCollection 2016 Oct 1.

    PubMed 27867733
  • Guanqun Zhang, Cottrell AC, Henry IC, McCombie DB. Assessment of pre-ejection period in ambulatory subjects using seismocardiogram in a wearable blood pressure monitor. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:3386-3389. doi: 10.1109/EMBC.2016.7591454.

    PubMed 28269030
  • Corino VD, Lombardi F, Mainardi LT. Blood pressure variability in patients with atrial fibrillation. Auton Neurosci. 2014 Oct;185:129-33. doi: 10.1016/j.autneu.2014.08.002. Epub 2014 Aug 17.

    PubMed 25183309
  • Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology. 2005 Aug;103(2):419-28; quiz 449-5. doi: 10.1097/00000542-200508000-00026.

    PubMed 16052125
  • Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.

    PubMed 18305265

Questions about this trial

What is this clinical trial studying?

An observational study of Patients in Surgical Intensive Care, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Title quality of pulsewave (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04261062, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in